ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$0.95
-0.02 (-2.27%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +282.5% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $0.95
Current
$0.95
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
151.5%
Low target
Base Case
$3.65
+282.5%
Avg target
Bull Case
$4.80
+403.0%
High target
Risk/Reward
2.7x
Favorable
Price in Context
Target vs 52W High
$3.65
-98.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%